Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, pursuant to the Answer of 16 October 2015 to Question 11615, on Everolimus, when he expects that a timetable for publication will be agreed.

NHS England is currently developingtwo policies for the provision of Everolimus – one for the Tuberous Sclerosis forComplex Related Renal Angiomyolipoma andone for SubependymalGiant Cell Astrocytoma (SEGA).

Once completed, each policy will need to be considered by the relevant clinical panels, the Clinical Priorities Advisory Group and the Specialised Commissioning Oversight Group. It is anticipated that this process will be completed over the coming months and that the policies are likely be published early in the new year.